Literatura Médica

A HISTÓRIA DA ECT

 

ENDLER, N. S. The Origins of Electroconvulsive Therapy (ECT). Convulsive therapy, v. 4, n. 1, p. 5–23, 1988. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/11940939>

PSELEK, S. et al. Celebrating the 80th anniversary of electroconvulsive therapy. Brazilian Journal of Psychiatry, v. 41, n. 1, p. 7–8, mar. 2019. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/30758460 >.

 

 

A ECT E A ESQUIZOFRENIA

 

ZERVAS, I. M.; THELERITIS, C.; SOLDATOS, C. R. Using ECT in schizophrenia: A review from a clinical perspective. The World Journal of Biological Psychiatry, v. 13, n. 2, p. 96–105, 12 fev. 2012. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/21486108>.

HUTANE, V. H. et al. Why do we prescribe ECT to schizophrenia patients? Indian journal of psychiatry, v. 53, n. 2, p. 149–51, abr. 2011. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/21772648>.

 

 

A ECT E A DEPRESSÃO

 

UK ECT REVIEW GROUP. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. The Lancet, v. 361, n. 9360, p. 799–808, 8 mar. 2003. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/12642045>.

TAYLOR, J. J.; OSTROFF, R. Efficacy and Safety of Electroconvulsive Therapy in Depressive Disorders. [s.l.] Oxford University Press, 2018. v. 1 Disponível em: <https://www.ncbi.nlm.nih.gov/pubmed/12642045>

KELLNER, C. H. et al. Continuation Electroconvulsive Therapy vs Pharmacotherapy for Relapse Prevention in Major Depression. Archives of General Psychiatry, v. 63, n. 12, p. 1337–44, 1 dez. 2006. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/17146008>. Acesso em: 17 maio. 2019.

KELLNER, C. H'. et al. Depression Severity in Electroconvulsive Therapy (ECT) Versus Pharmacotherapy Trials. The Journal of ECT, v. 31, n. 1, p. 31–33, mar. 2015. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/24839981>.

PAGNIN, D. et al. Efficacy of ECT in depression: a meta-analytic review. The journal of ECT, v. 20, n. 1, p. 13–20, 1 mar. 2004. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/15087991>

AGARKAR, S. et al. ECT Use in Unipolar and Bipolar Depression. The Journal of ECT, v. 28, n. 3, p. e39–e40, set. 2012. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/22914639>

ALLARD, E. D. et al. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant. Journal of Psychiatric Research, v. 68, p. 68–73, 2015. Disponível em: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522045/pdf/nihms704936.pdf>.

 

 

ECT E MANIA

 

MUKHERJEE, S.; SACKEIM, H. A.; SCHNUR, D. B. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. The American journal of psychiatry, v. 151, n. 2, p. 169–76, fev. 1994. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/8296883>.

ELIAS, A. et al. Ultrabrief Electroconvulsive Therapy for Mania. The Journal of ECT, v. 32, n. 4, p. 270–272, dez. 2016. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/27191121>.

 

 

ECT: RISCOS E TAXA DE MORTALIDADE

 

TØRRING, N. et al. The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis. Acta Psychiatrica Scandinavica, v. 135, n. 5, p. 388–397, maio 2017. Disponível em < https://www.ncbi.nlm.nih.gov/pubmed/28332236>.

WATTS, B. V. et al. An Examination of Mortality and Other Adverse Events Related to Electroconvulsive Therapy Using a National Adverse Event Report System. The Journal of ECT, v. 27, n. 2, p. 105–108, jun. 2011. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/20966769>.

 

 

A ECT NA CLÍNICA PSIQUIÁTRICA

 

TESS, A. V.; SMETANA, G. W. Medical Evaluation of Patients Undergoing Electroconvulsive Therapy. New England Journal of Medicine, v. 360, n. 14, p. 1437–1444, 2 abr. 2009. Disponível em: <http://www.nejm.org/doi/abs/10.1056/NEJMra0707755>.

SACKEIM, H. A. et al. Effect of Concomitant Pharmacotherapy on Electroconvulsive Therapy Outcomes. Archives of General Psychiatry, v. 66, n. 7, p. 729, 1 jul. 2009. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/19581564>.

BOLWIG, T. G. How Does Electroconvulsive Therapy Work? Theories on its Mechanism. The Canadian Journal of Psychiatry, v. 56, n. 1, p. 13–18, jan. 2011. Disponível em: <http://journals.sagepub.com/doi/10.1177/070674371105600104>.

 

 

ECT NA GRAVIDEZ

 

ANDERSON, E. L.; RETI, I. M. ECT in Pregnancy: A Review of the Literature From 1941 to 2007. Psychosomatic Medicine, v. 71, n. 2, p. 235–242, fev. 2009. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/19073751>.

 

 

ECT EM IDOSOS

 

GROVER, S.; SOMAIYA, M. Electroconvulsive therapy in the elderly. Journal of Geriatric Mental Health, v. 4, n. 2, p. 74, 2017. Disponível em: <http://www.jgmh.org/text.asp?2017/4/2/74/221903>.

 

 

ECT EM ADOLESCENTES

 

GHAZIUDDIN, N. et al. Practice parameter for use of electroconvulsive therapy with adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, v. 43, n. 12, p. 1521–39, 1 dez. 2004b. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/15564821>.

 

 

A CETAMINA NO TRATAMENTO DA DEPRESSÃO

 

SERAFINI, G. et al. The role of ketamine in treatment-resistant depression: a systematic review. Current neuropharmacology, v. 12, n. 5, p. 444–61, set. 2014b. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/25426012>.

SERAFINI, G. et al. The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review. Current Neuropharmacology. [s.l: s.n.]. Disponível em: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243034/pdf/CN-12-444.pdf>.

AAN HET ROT, M. et al. Ketamine for Depression: Where Do We Go from Here? Biological Psychiatry, v. 72, n. 7, p. 537–547, 1 out. 2012. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/22705040>.

ABDALLAH, C. G. et al. The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation? Pharmacology & Therapeutics, v. 190, p. 148–158, out. 2018. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/29803629>. 

DIAZGRANADOS, N. et al. Rapid Resolution of Suicidal Ideation After a Single Infusion of an N -Methyl- D -Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder. The Journal of Clinical Psychiatry, v. 71, n. 12, p. 1605–1611, 15 dez. 2010. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/20673547>.


Kim J, Mierzwinski-Urban M. Ketamine for Treatment-Resistant Depression or Post-Traumatic Stress Disorder in Various Settings: A Review of Clinical Effectiveness, Safety, and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies  Health; 2017 Mar 1. Disponível em: < https://www.ncbi.nlm.nih.gov/books/NBK487457/>.

 

 

INFUSÃO DE CETAMINA NA CLÍNICA PSIQUIATRA

 

AAN HET ROT, M. et al. Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression. Biological Psychiatry, v. 67, n. 2, p. 139–145, 15 jan. 2010. Disponível em: <https://www.sciencedirect.com/science/article/pii/S000632230901097X>. 

KRYSTAL, J. H. et al. Ketamine: A Paradigm Shift for Depression Research and Treatment. Neuron, v. 101, n. 5, p. 774–778, 6 mar. 2019. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/30844397>.

BDALY, E. J. et al. Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression. JAMA Psychiatry, v. 75, n. 2, p. 139, 1 fev. 2018. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/29282469>